Omega Fund Management as of Dec. 31, 2018
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 14 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Replimune Group (REPL) | 37.8 | $51M | 5.1M | 10.00 | |
| Translate Bio | 13.6 | $18M | 2.4M | 7.50 | |
| Kezar Life Sciences (KZR) | 11.8 | $16M | 676k | 23.60 | |
| Paratek Pharmaceuticals | 9.9 | $13M | 2.6M | 5.13 | |
| Obseva Sa | 9.4 | $13M | 999k | 12.66 | |
| Fibrogen (FGEN) | 4.5 | $6.0M | 131k | 46.28 | |
| Cymabay Therapeutics | 3.2 | $4.3M | 552k | 7.87 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 2.6 | $3.5M | 1.5M | 2.35 | |
| Essa Pharma (EPIX) | 1.7 | $2.3M | 1.1M | 2.10 | |
| Pieris Pharmaceuticals | 1.5 | $2.1M | 778k | 2.66 | |
| Dicerna Pharmaceuticals | 1.3 | $1.8M | 167k | 10.69 | |
| Jounce Therapeutics | 1.3 | $1.8M | 530k | 3.37 | |
| Sienna Biopharmaceuticals (SNNAQ) | 1.3 | $1.8M | 759k | 2.32 | |
| Egalet | 0.0 | $0 | 2.9M | 0.00 |
